Dashboard
Manage Tickers

NGMNGM BIOPHARMACEUTICALS INC

Nasdaq ngmbio.com


$ 1.55 $ -0.02 (-1.28 %)    

Thursday, 04-Apr-2024 15:59:53 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 445.88 $ 2.85 (0.64 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.39 (0.46 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.83 (0.85 %)
$ 1.54
$ 1.56
$ 0.00 x 0
$ 0.00 x 0
$ 1.54 - $ 1.57
$ 0.60 - $ 4.69
2,390,830
na
127.04M
$ 0.79
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-11-2024 12-31-2023 10-K
2 11-02-2023 09-30-2023 10-Q
3 08-03-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 02-28-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 03-01-2022 12-31-2021 10-K
10 11-04-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 05-06-2021 03-31-2021 10-Q
13 03-15-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-12-2020 06-30-2020 10-Q
16 05-13-2020 03-31-2020 10-Q
17 03-17-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-12-2019 06-30-2019 10-Q
20 05-16-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ngm-bio-to-present-two-posters-highlighting-clinical-data-from-ongoing-phase-12-clinical-trial-of-ngm707-a-dual-ilt2ilt4-antagonist-antibody-product-candidate-at-aacr-2024-annual-meeting
NGM Bio To Present Two Posters Highlightin...
03/19/2024 21:32:02

raymond-james-downgrades-ngm-biopharmaceuticals-to-market-perform
Raymond James Downgrades NGM Biopharmaceut...
03/12/2024 09:24:58

Raymond James analyst Steven Seedhouse downgrades NGM Biopharmaceuticals (NASDAQ:NGM) from Outperform to Market Perform.

ngm-biopharmaceuticals-q4-eps-033-beats-039-estimate-sales-16500k-miss-56000k-estimate
NGM Biopharmaceuticals Q4 EPS $(0.33) Beat...
03/11/2024 20:20:24

NGM Biopharmaceuticals (NASDAQ:NGM) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of...

td-cowen-downgrades-ngm-biopharmaceuticals-to-market-perform-lowers-price-target-to-155
TD Cowen Downgrades NGM Biopharmaceuticals...
02/28/2024 11:44:09

TD Cowen analyst Ritu Baral downgrades NGM Biopharmaceuticals (NASDAQ:NGM) from Outperform to Market Perform and lowers the ...

why-freshpet-shares-are-trading-higher-by-around-15-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Freshpet Shares Are Trading Higher By ...
02/26/2024 18:57:55

Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter...

why-is-cancer-focused-ngm-biopharmaceuticals-stock-trading-lower-on-monday
Why Is Cancer-Focused NGM Biopharmaceutica...
02/26/2024 18:15:44

Explore NGM Bio's acquisition news by The Column Group at $1.55/share, an 80% premium. Learn about the recent Phase 1b stud...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
02/26/2024 17:31:06

ngm-biopharmaceuticals-shares-resume-trade
NGM Biopharmaceuticals Shares Resume Trade
02/26/2024 14:50:31

trading-halt-halt-status-updated-at-94500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 9:45:...
02/26/2024 14:45:06

ngm-bio-has-entered-into-a-definitive-agreement-and-plan-of-merger-with-certain-affiliates-of-the-column-group-lp-ngm-bio-stockholders-to-receive-155-per-share-in-cash-total-equity-value-of-135m
NGM Bio Has Entered Into A Definitive Agre...
02/26/2024 14:05:16

NGM Bio stockholders to receive $1.55 per share in cash, an 80% premium over the closing share price on the last trading day pr...

looking-into-ngm-biopharmaceuticalss-recent-short-interest
Looking Into NGM Biopharmaceuticals's Rece...
01/19/2024 13:30:20

why-jetblue-airways-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why JetBlue Airways Shares Are Trading Low...
01/09/2024 18:00:59

Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session.

ngm-bio-announces-clinical-data-from-trial-of-ngm707-in-advanced-solid-tumors-and-outlines-evolved-strategy-for-aldafermin-and-ngm120
NGM Bio Announces Clinical Data From Trial...
01/09/2024 13:05:22

Encouraging findings in heavily pretreated patients in multiple solid tumor indications, including MSS colorectal cancer (CRC),...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
01/02/2024 17:31:04

why-ngm-biopharmaceuticals-stock-is-blasting-higher
Why NGM Biopharmaceuticals Stock Is Blasti...
01/02/2024 17:30:29

NGM Biopharmaceuticals, Inc.

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
01/02/2024 13:05:43

ngm-biopharmaceuticals-confirmed-it-received-a-non-binding-expression-of-interest-from-the-column-group-regarding-potential-acquisition-of-all-outstanding-shares-of-common-stock-of-the-company-not-already-owned-by-tcg-in-a-going-private-transaction
Ngm Biopharmaceuticals Confirmed It Receiv...
01/02/2024 12:36:18

NGM Biopharmaceuticals, Inc. ("NGM Bio" or the "Company") today confirmed that it has received a non-bindingexp...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
01/01/2024 21:30:54

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
12/29/2023 21:31:10

b-riley-securities-maintains-buy-rating-for-ngm-biopharmaceuticals-heres-what-you-need-to-know
B. Riley Securities Maintains Buy Rating f...
11/22/2023 17:00:10

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION